Catalent Appoints Joseph A. Ferraro As Senior Vice President, General Counsel, Chief Compliance Officer, And Secretary
February 14, 2023
February 14, 2023
SOMERSET, New Jersey, Feb. 14 (TNSper) -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on Feb. 13, 2023:
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and . . .
Catalent, Inc. (NYSE: CTLT), the leader in enabling the development and supply of better treatments for patients worldwide, today announced the appointment of Joseph A. Ferraro as Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary. Mr. Ferraro will be responsible for managing Catalent's global legal and . . .